Work

Encouraging Survival and High Rates of Toxicity: Allogeneic Hematopoietic Cell Transplantation after Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Aggressive Lymphoma Patients

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-147148

Authors: Shalev Fried, Ivetta Danylesko, Ronit Yerushalmi, Noga Shem-Tov, Roni Shouval, Joshua A Fein, Zachary Cohen, Elad Jacoby, Michal Besser, Arnon Nagler, Avichai Shimoni, Abraham Avigdor

Institutions: Tel Aviv University, Sheba Medical Center, Memorial Sloan Kettering Cancer Center, University of Connecticut, UConn Health, Edmond and Lily Safra Children's Hospital

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3211604201

Cites:

Cited by: 1

Related to: 10